Martin Luther University
Also known as: Asklepios Krankenhaus Weissenfels | Dr. Petra Tschanter | Hans-Joachim Schmoll, MD | Karin Jordan | Martin-Luther-Universität Halle-Wittenberg | Martin-Luther-University Halle-Wittenberg | Martin-Luther-University Halle-Wittenberg, Medical Faculty | Medical Faculty of the Martin-Luther-University Halle-Wittenberg, Germany | MLU, Institut für Agrar-und Ernährungswissenschaften | PD Dr. med. Matthias Dollinger | Thomas Kuhnt | Ulrike Lehmann | University Hospital and Polyclinic for Internal Medicine I, Martin-Luther-University Halle, Germany
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2000Last known activity
Jun 17, 2024
Timeline
1500s
- Jan 1, 1502
Martin Luther University— Founded
Drugs by trial phase (56 distinct, 40 trials)
Phase 4 (11 own, 0 via acquisition)
Phase 3 (10 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Adenoma
- Adenoma, Villous
- Anemia
- Back Pain
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Colorectal Neoplasms
- Depression
- Endophthalmitis
- Glioma
- Hodgkin Disease
- Inflammation
- Kidney Diseases
- Low Back Pain
- Lymphoma
- Multiple Organ Failure
- Rectal Neoplasms
- Schizophrenia
- Stomach Neoplasms
- Strabismus
- Syndrome
- Uterine Cervical Neoplasms
- Vomiting
- Xerostomia
Recent trials (50)
- NCT06414031Sponsor investigatorPhase 3Jun 17, 2024
- NCT06414031OfficialPhase 3Jun 17, 2024
- NCT06414031Lead sponsorPhase 3Jun 17, 2024
- NCT05075122Lead sponsorPhase 2Aug 2, 2021
- NCT05075122Reponsible party - principal investigatorPhase 2Aug 2, 2021
- NCT03771924Reponsible party - principal investigatorN/AFeb 28, 2019
- NCT03771924Study directorN/AFeb 28, 2019
- NCT03771924Lead sponsorN/AFeb 28, 2019
- NCT03620812Reponsible party - principal investigatorN/AAug 16, 2018
- NCT03620812Study directorN/AAug 16, 2018
- NCT03620812Lead sponsorN/AAug 16, 2018
- NCT03454282CollaboratorN/AMay 24, 2018
- NCT03499327CollaboratorN/AMar 5, 2018
- NCT03071796Reponsible party - principal investigatorN/AMar 7, 2017
- NCT03071796Lead sponsorN/AMar 7, 2017
Details
- Founded
- Halle, DE Jan 1, 1502
- Last known activity
- Jun 17, 2024